Description
Elranatamab is indicated for the treatment of adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody
How and where to buy elranatamab?
Elranatamab-bcmm is a Generic Name for the trade name drug Elrexfio®. Elrexfio® is manufactured by Pfizer Inc. Elrexfio® is approved by the FDA. Date of first approval: August 14, 2023. Elrexfio® is supplied as Injections: 76 mg/1.9 mL (40 mg/mL) and 44 mg/1.1 mL (40 mg/mL) in a single-dose vial for subcutaneous use.
Get Access to ELREXFIO (elranatamab-bcmm) injection In India
On request it available to patient and doctors. Medvitaz Pharma is equipped to facilitate the distribution of ELREXFIO (elranatamab-bcmm) injection (prescription medications) worldwide and throughout India upon completion of necessary legal procedures, if applicable.
To inquire about the price of either the branded medication “ELREXFIO (elranatamab-bcmm) injection” or the generic version “elranatamab-bcmm” for personal use under patient-specific treatment in various cities including Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim, and others in India, please fill out the request form. Upon receiving your request and assessing the delivery process, we will provide you with an estimated price for the medication within 24 hours.
For any inquiries or assistance, please reach out to our Patient Support Team. We are available to assist you from Monday to Friday, between 9:00 and 19:00 IST. You can contact us via email at [email protected], toll-free at +91 8750295029, or through WhatsApp at +91-8750295029.